DVA:NYE-DaVita Inc.

EQUITY | Medical Care | New York Stock Exchange

Last Closing

USD 56.95

Change

+0.05 (+0.09)%

Market Cap

USD 12.45B

Volume

2.01M

Analyst Target

USD 66.56
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

DaVita Inc, formerly DaVita HealthCare Partners Inc operates kidney dialysis centers and provides related lab services in dialysis centers and in contracted hospitals across USA. It also operates other ancillary services and strategic initiatives.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Medical Care

ETFs Containing DVA

SANE 4.09 % 0.00 %

N/A

N/A
FLAG 0.00 % 1.52 %

N/A

N/A
PHB Invesco Fundamental High .. 0.00 % 0.50 %

+0.05 (+0%)

USD 0.68B
BACK:LSE 0.00 % 0.00 %

N/A

N/A
SLIM 0.00 % 0.50 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.67% 63% D 44% F
Dividend Return N/A N/A N/A N/A F
Total Return 10.67% 63% D 39% F
Trailing 12 Months  
Capital Gain -20.65% 38% F 18% F
Dividend Return N/A N/A N/A N/A F
Total Return -20.65% 38% F 16% F
Trailing 5 Years  
Capital Gain -22.26% 46% F 29% F
Dividend Return N/A N/A N/A N/A F
Total Return -22.26% 46% F 22% F
Average Annual (5 Year Horizon)  
Capital Gain -4.86% 53% F 27% F
Dividend Return -4.86% 53% F 24% F
Total Return N/A N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) 13.54% 95% A 78% C+
Risk Adjusted Return -35.91% 42% F 19% F
Market Capitalization 12.45B 84% B 84% B

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.10 14% 8%
Price/Book Ratio 2.45 26% 35%
Price / Cash Flow Ratio 0.00 61% 79%
Price/Free Cash Flow Ratio 0.00 61% 75%
Management Effectiveness  
Return on Equity 13.00% 53% 72%
Return on Invested Capital N/A N/A N/A
Return on Assets 4.39% 47% 68%
Debt to Equity Ratio 213.64% 11% 14%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector